COVID-19 Video

The COVID-19 pandemic has had a considerable impact on people’s lives around the world. Diverted healthcare resources and social distancing restrictions have introduced additional barriers and challenges to diagnosing patients with viral hepatitis and linking them into care. To understand more about the global impact of COVID-19, we asked ten experts from around the world to share their experience of how the COVID-19 pandemic has affected viral hepatitis screening, diagnosis and linkage to care in their setting.

Watch the video to find out more about how care has evolved for the experts and hear their insights into the future of patient management.

The impact of COVID-19 on viral hepatitis screening and linkage to care

Did you find the video informative and relevant to your setting/country?
Loading ... Loading ...

The impact of COVID-19 on viral hepatitis screening and linkage to care

Click on the videos below to find out more about the impact that COVID-19 has had on viral hepatitis screening and linkage to care across the globe

 

Australia

Dr Joss O’Loan – Kombi Clinic

 

Beligum

Tessa Windelinckx – The Antwerp Free Clinic

 

Belgium

Griet Maertens – The Antwerp Free Clinic

 

Belgium

The Antwerp Free Clinic and Dr Stefan Bourgeois

 

France

Professor André-Jean Remy – Perpignan Hospital

 

Germany

Dirk Schaffer – Deutsche AIDS-Hilfe

 

Italy

Dr Elisabetta Teti – Tor Vergata University of Rome

 

Spain

Dr Sabela Lens – Hospital Clinic Barcelona

 

Taiwan

Dr Ming-Lung Yu – Kaohsiung Medical University

 

United Kingdom

Rachel Halford – The Hepatitis C Trust

 

United Kingdom

Dr Iain Brew – Health in Justice

 

USA

Dr Anthony Martinez – University of Buffalo

The evolution of viral hepatitis screening and linkage to care during the COVID-19 pandemic

Click on the videos below to find out more about how viral hepatitis screening and linkage to care evolved across the globe during the COVID-19 pandemic

 

Australia

Dr Joss O’Loan – Kombi Clinic

 

Belgium

Griet Maertens – The Antwerp Free Clinic

 

Belgium

Tessa Windelinckx – The Antwerp Free Clinic

 

Belgium

Danny Persy – The Antwerp Free Clinic

 

France

Professor André-Jean Remy – Perpignan Hospital

 

Germany

Dirk Schaffer – Deutsche AIDS-Hilfe

 

Italy

Dr Elisabetta Teti – Tor Vergata University of Rome

 

Spain

Dr Sabela Lens – Hospital Clinic Barcelona

 

Taiwan

Dr Ming-Lung Yu – Kaohsiung Medical University

 

United Kingdom

Rachel Halford – The Hepatitis C Trust

 

USA

Dr Anthony Martinez – University of Buffalo

Viral hepatitis screening and linkage to care in a post-COVID-19 era

Click on the videos below to find out more about what viral hepatitis screening and linkage to care will look like in a post-COVID-19 era

 

Australia

Dr Joss O’Loan – Kombi Clinic

 

France

Professor André-Jean Remy – Perpignan Hospital

 

Germany

Dirk Schaffer – Deutsche AIDS-Hilfe

 

Italy

Dr Elisabetta Teti – Tor Vergata University of Rome

 

Spain

Dr Sabela Lens – Hospital Clinic Barcelona

 

Taiwan

Dr Ming-Lung Yu – Kaohsiung Medical University

 

United Kingdom

Rachel Halford – The Hepatitis C Trust

 

United Kingdom

Dr Iain Brew – Health in Justice

 

USA

Dr Anthony Martinez – University of Buffalo

Screening and Linkage to Care Summit 2020

There are many examples of good practice initiatives which are enhancing progress towards viral hepatitis elimination, find out more about some of these initiatives here

The annual SLTC Summit is well known for bringing all stakeholders together by providing a platform for colleagues and peers from around the world to connect and share insights. As we embark on a digital format for this year, it's more important now than ever before to keep the conversations going! To hear more from the experts, click below.

IHQ-HCV-2020-07-0031 • Date of preparation: September 2020